Esperion Therapeutics, Inc.
Ticker: 1434868
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 80.10-8.3% | 87.31+6.0% | 82.39+26.8% | 65.00+25.9% | 51.63-30.1% | 73.83-46.4% | 137.74+305.5% | 33.97 |
| Total Income | 80.10-8.3% | 87.31+6.0% | 82.39+26.8% | 65.00+25.9% | 51.63-30.1% | 73.83-46.4% | 137.74+305.5% | 33.97 |
| EXPENSES | ||||||||
| Expenditure | 86.69-10.9% | 97.27+29.2% | 75.29-13.5% | 87.09+28.7% | 67.66-5.1% | 71.26+8.8% | 65.47+6.5% | 61.50 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| Net Profit | -25.20+19.6% | -31.33-146.1% | -12.73+68.5% | -40.46-37.1% | -29.52+52.3% | -61.93-201.5% | 61.02+247.9% | -41.25 |
| KEY METRICS | ||||||||
| OPM % | -8.22%+3.19pp | -11.41%-20.02pp | 8.61%+42.61pp | -34.00%-2.96pp | -31.04%-34.53pp | 3.49%-48.98pp | 52.47%+133.52pp | -81.05% |
| NPM % | -31.45%+4.43pp | -35.89%-20.44pp | -15.45%+46.80pp | -62.24%-5.06pp | -57.18%+26.69pp | -83.87%-128.18pp | 44.30%+144.30pp | -100.00% |
| EPS | -0.10+37.5% | -0.16-166.7% | -0.06+71.4% | -0.21-40.0% | -0.15+54.5% | -0.33-191.7% | 0.36+197.3% | -0.37 |
Corporate Events
Board MeetingESPR
20268Jul
Board Meeting
Stockholders voted on the adoption of the Agreement and Plan…
SEC Filing ↗ Board MeetingESPR
202628May
Board Meeting
Annual Meeting of Stockholders to elect two Class I director…
SEC Filing ↗